default author photo

Julia M. Adler

Free University of Berlin (FUB) - Institut für Virologie

Germany

  • Free University of Berlin (FUB) - Institut für Virologie

SCHOLARLY PAPERS

2

DOWNLOADS

93

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Development of Safe and Highly Protective Live-Attenuated SARS-CoV-2 Vaccine Candidates by Genome Recoding

Number of pages: 43 Posted: 10 Feb 2021
Jakob Trimpert, Kristina Dietert, Nadine Ebert, Tran Thi Nhu Thao, Daria Vladimirova, Susanne Kaufer, Fabien Labroussaa, Azza Abdelgawad, Andelé Conradie, Thomas Höfler, Julia M. Adler, Luca Bertzbach, Joerg Jores, Achim Gruber, Volker Thiel, Nikolaus Osterrieder and Dusan Kunec
Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Tierpathologie, University of Bern - Institute of Virology and Immunology, University of Bern - Institute of Virology and Immunology, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Virologie, University of Bern - Department of Infectious Diseases and Pathobiology, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Virologie, University of Bern - Department of Infectious Diseases and Pathobiology, Free University of Berlin (FUB) - Institut für Tierpathologie, University of Bern - Institute of Virology and Immunology, Free University of Berlin (FUB) - Institut für Virologie and Free University of Berlin (FUB) - Institut für Virologie
Downloads 56 (1,000,027)
Citation 1

Abstract:

Loading...

coronavirus, SARS-CoV-2, COVID-19, live attenuated vaccine, genome recoding, codon pair deoptimization, synthetic attenuated virus engineering, Syrian hamster

2.

Preclinial Safety and Efficacy of a Therapeutic Antibody That Targets SARS-CoV-2 at the Sotrovimab Face But is Escaped by Omicron

Number of pages: 49 Posted: 17 Aug 2022
Jakob Kreye, S. Momsen Reincke, Stefan Edelburg, Lara M. Jeworowski, Hans-Christian Kornau, Jakob Trimpert, Peter Hombach, Sophia Halbe, Volker Nölle, Martin Meyer, Stefanie Kattenbach, Elisa Sánchez-Sendin, Marie Luisa Schmidt, Tatjana Schwarz, Ruben Rose, Andi Krumbholz, Sophie Merz, Julia M. Adler, Kathrin Eschke, Azza Abdelgawad, Dietmar Schmitz, Leif E. Sander, Uwe Janssen, Victor M. Corman and Harald Prüß
German Center for Neurodegenerative Diseases (DZNE), German Center for Neurodegenerative Diseases (DZNE), Miltenyi Biotec B.V. & Co. KG, Berlin Institute of Health - Institute of Virology, German Center for Neurodegenerative Diseases (DZNE), Free University of Berlin (FUB) - Institut für Virologie, Miltenyi Biotec B.V. & Co. KG, Miltenyi Biotec B.V. & Co. KG, Miltenyi Biotec B.V. & Co. KG, Miltenyi Biotec B.V. & Co. KG, Miltenyi Biotec B.V. & Co. KG, German Center for Neurodegenerative Diseases (DZNE), Charité - Universitätsmedizin Berlin - Institute of Virology, Charité - Universitätsmedizin Berlin - Institute of Virology, Christian Albrechts-University of Kiel - Institute for Infection Medicine, Christian Albrechts-University of Kiel - Institute for Infection Medicine, IDEXX Laboratories, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Virologie, German Center for Neurodegenerative Diseases (DZNE), Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Miltenyi Biotec B.V. & Co. KG, Charité - Universitätsmedizin Berlin - Institute of Virology and German Center for Neurodegenerative Diseases (DZNE)
Downloads 37 (1,222,651)

Abstract:

Loading...

COVID-19, SARS-CoV-2, therapeutic antibody, variant of concern, potency breadth, hamster model, human membrane protein library, human tissue cross-reactivity study, Omicron, N440K